Copyright Reports & Markets. All rights reserved.

Global Oncology Treatment Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Oncology Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Chemotherapy
    • 1.2.3 Targeted Therapy
    • 1.2.4 Immunotherapy (Biologic Therapy)
    • 1.2.5 Hormonal Therapy
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Oncology Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Blood Cancer
    • 1.3.3 Breast Cancer
    • 1.3.4 Gastrointestinal Cancer
    • 1.3.5 Prostate Cancer
    • 1.3.6 Respiratory/Lung Cancer
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Oncology Treatment Drug Market Perspective (2016-2027)
  • 2.2 Oncology Treatment Drug Growth Trends by Regions
    • 2.2.1 Oncology Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Oncology Treatment Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Oncology Treatment Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Oncology Treatment Drug Industry Dynamic
    • 2.3.1 Oncology Treatment Drug Market Trends
    • 2.3.2 Oncology Treatment Drug Market Drivers
    • 2.3.3 Oncology Treatment Drug Market Challenges
    • 2.3.4 Oncology Treatment Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oncology Treatment Drug Players by Revenue
    • 3.1.1 Global Top Oncology Treatment Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Oncology Treatment Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oncology Treatment Drug Revenue
  • 3.4 Global Oncology Treatment Drug Market Concentration Ratio
    • 3.4.1 Global Oncology Treatment Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Treatment Drug Revenue in 2020
  • 3.5 Oncology Treatment Drug Key Players Head office and Area Served
  • 3.6 Key Players Oncology Treatment Drug Product Solution and Service
  • 3.7 Date of Enter into Oncology Treatment Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Treatment Drug Breakdown Data by Type

  • 4.1 Global Oncology Treatment Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Oncology Treatment Drug Forecasted Market Size by Type (2022-2027)

5 Oncology Treatment Drug Breakdown Data by Application

  • 5.1 Global Oncology Treatment Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Oncology Treatment Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Oncology Treatment Drug Market Size (2016-2027)
  • 6.2 North America Oncology Treatment Drug Market Size by Type
    • 6.2.1 North America Oncology Treatment Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Oncology Treatment Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Oncology Treatment Drug Market Size by Type (2016-2027)
  • 6.3 North America Oncology Treatment Drug Market Size by Application
    • 6.3.1 North America Oncology Treatment Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Oncology Treatment Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Oncology Treatment Drug Market Size by Application (2016-2027)
  • 6.4 North America Oncology Treatment Drug Market Size by Country
    • 6.4.1 North America Oncology Treatment Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Oncology Treatment Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Oncology Treatment Drug Market Size (2016-2027)
  • 7.2 Europe Oncology Treatment Drug Market Size by Type
    • 7.2.1 Europe Oncology Treatment Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Oncology Treatment Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Oncology Treatment Drug Market Size by Type (2016-2027)
  • 7.3 Europe Oncology Treatment Drug Market Size by Application
    • 7.3.1 Europe Oncology Treatment Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Oncology Treatment Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Oncology Treatment Drug Market Size by Application (2016-2027)
  • 7.4 Europe Oncology Treatment Drug Market Size by Country
    • 7.4.1 Europe Oncology Treatment Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Oncology Treatment Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology Treatment Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Oncology Treatment Drug Market Size by Type
    • 8.2.1 Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Oncology Treatment Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Oncology Treatment Drug Market Size by Application
    • 8.3.1 Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Oncology Treatment Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Oncology Treatment Drug Market Size by Region
    • 8.4.1 Asia-Pacific Oncology Treatment Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Oncology Treatment Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Oncology Treatment Drug Market Size (2016-2027)
  • 9.2 Latin America Oncology Treatment Drug Market Size by Type
    • 9.2.1 Latin America Oncology Treatment Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Oncology Treatment Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Oncology Treatment Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Oncology Treatment Drug Market Size by Application
    • 9.3.1 Latin America Oncology Treatment Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Oncology Treatment Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Oncology Treatment Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Oncology Treatment Drug Market Size by Country
    • 9.4.1 Latin America Oncology Treatment Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Oncology Treatment Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology Treatment Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Oncology Treatment Drug Market Size by Type
    • 10.2.1 Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Oncology Treatment Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Oncology Treatment Drug Market Size by Application
    • 10.3.1 Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Oncology Treatment Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Oncology Treatment Drug Market Size by Country
    • 10.4.1 Middle East & Africa Oncology Treatment Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Oncology Treatment Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Oncology Treatment Drug Introduction
    • 11.1.4 Roche Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.1.5 Roche Recent Development
  • 11.2 Celgene
    • 11.2.1 Celgene Company Details
    • 11.2.2 Celgene Business Overview
    • 11.2.3 Celgene Oncology Treatment Drug Introduction
    • 11.2.4 Celgene Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.2.5 Celgene Recent Development
  • 11.3 Novartis
    • 11.3.1 Novartis Company Details
    • 11.3.2 Novartis Business Overview
    • 11.3.3 Novartis Oncology Treatment Drug Introduction
    • 11.3.4 Novartis Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.3.5 Novartis Recent Development
  • 11.4 Bristol-Myers Squibb
    • 11.4.1 Bristol-Myers Squibb Company Details
    • 11.4.2 Bristol-Myers Squibb Business Overview
    • 11.4.3 Bristol-Myers Squibb Oncology Treatment Drug Introduction
    • 11.4.4 Bristol-Myers Squibb Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.4.5 Bristol-Myers Squibb Recent Development
  • 11.5 Johnson & Johnson
    • 11.5.1 Johnson & Johnson Company Details
    • 11.5.2 Johnson & Johnson Business Overview
    • 11.5.3 Johnson & Johnson Oncology Treatment Drug Introduction
    • 11.5.4 Johnson & Johnson Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.5.5 Johnson & Johnson Recent Development
  • 11.6 Merck & Co.
    • 11.6.1 Merck & Co. Company Details
    • 11.6.2 Merck & Co. Business Overview
    • 11.6.3 Merck & Co. Oncology Treatment Drug Introduction
    • 11.6.4 Merck & Co. Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.6.5 Merck & Co. Recent Development
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Oncology Treatment Drug Introduction
    • 11.7.4 AstraZeneca Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.7.5 AstraZeneca Recent Development
  • 11.8 Pfizer
    • 11.8.1 Pfizer Company Details
    • 11.8.2 Pfizer Business Overview
    • 11.8.3 Pfizer Oncology Treatment Drug Introduction
    • 11.8.4 Pfizer Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.8.5 Pfizer Recent Development
  • 11.9 Amgen
    • 11.9.1 Amgen Company Details
    • 11.9.2 Amgen Business Overview
    • 11.9.3 Amgen Oncology Treatment Drug Introduction
    • 11.9.4 Amgen Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.9.5 Amgen Recent Development
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Company Details
    • 11.10.2 Eli Lilly Business Overview
    • 11.10.3 Eli Lilly Oncology Treatment Drug Introduction
    • 11.10.4 Eli Lilly Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.10.5 Eli Lilly Recent Development
  • 11.11 AbbVie
    • 11.11.1 AbbVie Company Details
    • 11.11.2 AbbVie Business Overview
    • 11.11.3 AbbVie Oncology Treatment Drug Introduction
    • 11.11.4 AbbVie Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.11.5 AbbVie Recent Development
  • 11.12 Takeda
    • 11.12.1 Takeda Company Details
    • 11.12.2 Takeda Business Overview
    • 11.12.3 Takeda Oncology Treatment Drug Introduction
    • 11.12.4 Takeda Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.12.5 Takeda Recent Development
  • 11.13 Astellas
    • 11.13.1 Astellas Company Details
    • 11.13.2 Astellas Business Overview
    • 11.13.3 Astellas Oncology Treatment Drug Introduction
    • 11.13.4 Astellas Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.13.5 Astellas Recent Development
  • 11.14 Ipsen
    • 11.14.1 Ipsen Company Details
    • 11.14.2 Ipsen Business Overview
    • 11.14.3 Ipsen Oncology Treatment Drug Introduction
    • 11.14.4 Ipsen Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.14.5 Ipsen Recent Development
  • 11.15 Sanofi
    • 11.15.1 Sanofi Company Details
    • 11.15.2 Sanofi Business Overview
    • 11.15.3 Sanofi Oncology Treatment Drug Introduction
    • 11.15.4 Sanofi Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.15.5 Sanofi Recent Development
  • 11.16 Bayer
    • 11.16.1 Bayer Company Details
    • 11.16.2 Bayer Business Overview
    • 11.16.3 Bayer Oncology Treatment Drug Introduction
    • 11.16.4 Bayer Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.16.5 Bayer Recent Development
  • 11.17 Biogen Idec
    • 11.17.1 Biogen Idec Company Details
    • 11.17.2 Biogen Idec Business Overview
    • 11.17.3 Biogen Idec Oncology Treatment Drug Introduction
    • 11.17.4 Biogen Idec Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.17.5 Biogen Idec Recent Development
  • 11.18 Teva
    • 11.18.1 Teva Company Details
    • 11.18.2 Teva Business Overview
    • 11.18.3 Teva Oncology Treatment Drug Introduction
    • 11.18.4 Teva Revenue in Oncology Treatment Drug Business (2016-2021)
    • 11.18.5 Teva Recent Development
  • 11.18 Otsuka

.1 Otsuka Company Details

    .2 Otsuka Business Overview

      .3 Otsuka Oncology Treatment Drug Introduction

        .4 Otsuka Revenue in Oncology Treatment Drug Business (2016-2021)

          .5 Otsuka Recent Development

          • 11.20 Eisai
            • 11.20.1 Eisai Company Details
            • 11.20.2 Eisai Business Overview
            • 11.20.3 Eisai Oncology Treatment Drug Introduction
            • 11.20.4 Eisai Revenue in Oncology Treatment Drug Business (2016-2021)
            • 11.20.5 Eisai Recent Development
          • 11.21 Merck KGaA
            • 11.21.1 Merck KGaA Company Details
            • 11.21.2 Merck KGaA Business Overview
            • 11.21.3 Merck KGaA Oncology Treatment Drug Introduction
            • 11.21.4 Merck KGaA Revenue in Oncology Treatment Drug Business (2016-2021)
            • 11.21.5 Merck KGaA Recent Development
          • 11.22 Gilead Sciences
            • 11.22.1 Gilead Sciences Company Details
            • 11.22.2 Gilead Sciences Business Overview
            • 11.22.3 Gilead Sciences Oncology Treatment Drug Introduction
            • 11.22.4 Gilead Sciences Revenue in Oncology Treatment Drug Business (2016-2021)
            • 11.22.5 Gilead Sciences Recent Development

          12 Analyst's Viewpoints/Conclusions

            13 Appendix

            • 13.1 Research Methodology
              • 13.1.1 Methodology/Research Approach
              • 13.1.2 Data Source
            • 13.2 Disclaimer

            Global Oncology Treatment Drug Scope and Market Size
            Oncology Treatment Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Treatment Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

            Segment by Type
            Chemotherapy
            Targeted Therapy
            Immunotherapy (Biologic Therapy)
            Hormonal Therapy
            Others

            Segment by Application
            Blood Cancer
            Breast Cancer
            Gastrointestinal Cancer
            Prostate Cancer
            Respiratory/Lung Cancer
            Others

            By Region
            North America
            United States
            Canada
            Europe
            Germany
            France
            U.K.
            Italy
            Russia
            Nordic
            Rest of Europe
            Asia-Pacific
            China
            Japan
            South Korea
            Southeast Asia
            India
            Australia
            Rest of Asia
            Latin America
            Mexico
            Brazil
            Rest of Latin America
            Middle East & Africa
            Turkey
            Saudi Arabia
            UAE
            Rest of MEA

            By Company
            Roche
            Celgene
            Novartis
            Bristol-Myers Squibb
            Johnson & Johnson
            Merck & Co.
            AstraZeneca
            Pfizer
            Amgen
            Eli Lilly
            AbbVie
            Takeda
            Astellas
            Ipsen
            Sanofi
            Bayer
            Biogen Idec
            Teva
            Otsuka
            Eisai
            Merck KGaA
            Gilead Sciences

            Buy now